Completed OBSERVATIONAL NCT01624506

Observational Study of Anti-Reflux Surgery

Observational Study of Anti-Reflux Surgery: Clinical Experience With the LINX Reflux Management System and Fundoplication

Sponsor: Torax Medical Incorporated

Conditions GERD Gastro Esophageal Reflux Gastroesophageal Reflux

Updated 9 times since 2017 Last updated: May 13, 2021 Started: Jan 31, 2010 Primary completion: Jan 31, 2015 Completion: Jul 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates GERD and Gastro Esophageal Reflux and is currently completed. Torax Medical Incorporated leads this study, which shows 9 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Sep 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Sep 2021 [monthly]

Completed

▶ Show 4 earlier versions

Aug 2018 — Jan 2021 [monthly]

Completed
Jun 2018 — Aug 2018 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Torax Medical Incorporated

Data source: Torax Medical Incorporated

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Berlin, Germany , Birmingham, United Kingdom , Bottrop, Germany , Bremen, Germany , Castrop-Rauxel, Germany , Cologne, Germany , Epsom, United Kingdom , Exeter, United Kingdom , Forchheim, Germany , Herne, Germany and 10 more locations